Patents Assigned to SYNTAB THERAPEUTICS GMBH
  • Synthetic compound
    Patent number: 11318208
    Abstract: The present invention relates to a synthetic compound comprising at least one effector moiety and at least one binder moiety, wherein the effector moiety is associated to the binder moiety, and wherein further the effector moiety comprises a N-formyl methionine peptide which comprises an isoleucine residue (FIG. 1).
    Type: Grant
    Filed: May 24, 2017
    Date of Patent: May 3, 2022
    Assignee: SYNTAB THERAPEUTICS GMBH
    Inventors: Christian Becker, Manuel Brehs, Karine Thewes, Ute Steinbusch, Andre J G Pötgens, Janett Schwarz